Pediatric Rheumatology

pediatric rheumatology banner

Latest News

Internet Intervention Improves Pain, QoL in Juvenile Idiopathic Arthritis

Internet Intervention Improves Pain, QoL in Juvenile Idiopathic Arthritis

Psychoeducational treatments can aid in the transition to adult care, but this is often lacking for teens due to access issues.

Pregnancy Outcomes in SLE vs Other Connective Tissue, Inflammatory Rheumatic Conditions

Pregnancy Outcomes in SLE vs Other Connective Tissue, Inflammatory Rheumatic Conditions

Real-world data indicate that although most patients with systemic lupus erythematosus or connective tissue diseases have successful pregnancies, more adverse pregnancy outcomes occur.

Anti-Tumor Necrosis Factor Agents vs csDMARDs for Pediatric Enthesitis-Related Arthritis

Anti-Tumor Necrosis Factor Agents vs csDMARDs for Pediatric Enthesitis-Related Arthritis

In children with enthesitis-related arthritis, the use of anti-tumor necrosis factor (TNF) agents within the first year of diagnosis has demonstrated benefits in several clinically meaningful outcomes.

Juvenile Idiopathic Arthritis Treated With Biologic Therapy: Risk Factors for Infection

Juvenile Idiopathic Arthritis Treated With Biologic Therapy: Risk Factors for Infection

Patients with juvenile idiopathic arthritis under biologic therapy in a real-world setting have high rates of serious infections.

Femoral Stress Index is Associated with Fracture Risk in School Age Children

Femoral Stress Index is Associated with Fracture Risk in School Age Children

The FSI proved to be at least as effective in predicting fracture risk in children as femoral and total body BMD.

Evolving Technologic Strategies for Managing Juvenile Idiopathic Arthritis

Evolving Technologic Strategies for Managing Juvenile Idiopathic Arthritis

Technological advances may assist children and adolescents with JIA, who are both more forgetful and more resistant to therapy.

New Assessment Tool Predicts Pediatric Fracture Risk

New Assessment Tool Predicts Pediatric Fracture Risk

A new bone assessment evaluates fracture risk in children.

B-Cell Depletion Predicts Rituximab Response in Systemic Lupus Erythematosus

B-Cell Depletion Predicts Rituximab Response in Systemic Lupus Erythematosus

Rituximab non-responders may still be amenable to B-cell targeted therapies, such as ofatumumab or obinutuzumab.

Juvenile Idiopathic Arthritis Subcutaneous Golimumab in Active Polyarticular-Course

Juvenile Idiopathic Arthritis Subcutaneous Golimumab in Active Polyarticular-Course

Golimumab use in children with active polyarticular-course JIA resulted in rapid, clinically meaningful improvements.

Guidelines to Identify Risks of Pediatric Psoriasis Comorbidities

Guidelines to Identify Risks of Pediatric Psoriasis Comorbidities

Risk factors for associated psoriasis comorbidities should be identified in patients with pediatric psoriasis.

Sign Up for Free e-newsletters